Raptor Pharmaceutical Corp Stock
Equities
US75382F1066
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
|
Managers | Title | Age | Since |
---|---|---|---|
Paul Hoelscher
DFI | Director of Finance/CFO | 59 | 16-10-24 |
Kim Lee
IRC | Investor Relations Contact | - | 14-10-22 |
Corporate Officer/Principal | 62 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Gregg Lapointe
CHM | Chairman | 65 | 14-12-31 |
Timothy Walbert
BRD | Director/Board Member | 57 | 11-04-10 |
Paul Hoelscher
DFI | Director of Finance/CFO | 59 | 16-10-24 |
1st Jan change | Capi. | |
---|---|---|
+20.12% | 126B | |
+25.25% | 119B | |
+25.56% | 27.95B | |
-19.51% | 20.5B | |
-14.36% | 17.12B | |
-15.63% | 16.1B | |
-46.67% | 14.97B | |
+11.89% | 14.84B | |
+57.74% | 14.38B |
- Stock Market
- Equities
- Stock